MJA
MJA

Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public

Med J Aust 2010; 192 (1): 33-36.

Summary

Objective: To investigate the Australian public’s expectations, concerns and willingness to accept vaccination with the pandemic (H1N1) 2009 influenza vaccine.

Design, setting and participants: A computer-assisted telephone interview survey was conducted between 20 August and 11 September 2009 by trained professional interviewers to study issues relating to vaccine uptake and perceived safety. The sample comprised 1155 randomly selected representative adults who had participated in a 2007 national study exploring knowledge and perceptions of pandemic influenza.

Main outcome measures: Likely acceptance of pandemic (H1N1) 2009 vaccination, factors associated with acceptance, and respondents’ willingness to share Australian vaccine with neighbouring developing countries.

Results: Of 1155 possible participants, 830 (72%) were successfully interviewed. Twenty per cent of the study group (169/830) reported that they had developed influenza-like symptoms during the 2009 pandemic period. Most respondents (645/830, 78%) considered pandemic (H1N1) 2009 to be a mild disease, and 211/830 (25%) regarded themselves as being at increased risk of infection. Willingness to accept pandemic (H1N1) 2009 vaccination was high (556/830, 67%) but was significantly lower than when pandemic vaccination uptake was investigated in 2007 (88%; P < 0.0001). Respondents who had already been vaccinated against seasonal influenza and those who perceived pandemic (H1N1) 2009 to be severe were significantly more willing to accept vaccination. Most respondents (793/822, 96%) were willing to share surplus vaccine with developing countries in our region.

Conclusion: Although two-thirds of Australian adults surveyed were willing to accept pandemic (H1N1) 2009 vaccination, and most supported sharing vaccine with developing countries, there is a need for accessible information on vaccine safety for those who are undecided about vaccination.

Please login with your free MJA account to view this article in full

  • Keith Eastwood1
  • David N Durrheim2
  • Alison Jones2
  • Michelle Butler1

  • 1 Hunter New England Population Health, Newcastle, NSW.
  • 2 University of Newcastle, Newcastle, NSW.


Acknowledgements: 

This study was funded by a National Health and Medical Research Council (NHMRC) research grant (Application ID 631098) to obtain information during the 2009 swine influenza pandemic. We gratefully acknowledge the Australian Government for funding this research and thank the interviewers for their diligence. The Australian Government had no role in the study design, data collection, analysis, interpretation or preparation of this manuscript.

Competing interests:

None identified.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article